Literature DB >> 971694

Plasma hormones in patients with advanced breast cancer treated with tamoxifen.

M P Golder, M E Phillips, D R Fahmy, P E Preece, V Jones, J M Henk, K Griffiths.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 971694     DOI： 10.1016/0014-2964(76)90022-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  8 in total

1.  Male gonadal function in coeliac disease: 2. Sex hormones.

Authors:  M J Farthing; L H Rees; C R Edwards; A M Dawson
Journal:  Gut       Date:  1983-02       Impact factor: 23.059

Review 2.  Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

3.  Recurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course.

Authors:  K J Willis; D R London; H W Ward; W R Butt; S S Lynch; B T Rudd
Journal:  Br Med J       Date:  1977-02-12

Review 4.  Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

5.  The effect of tamoxifen on GH and PRL secretion by human pituitary tumors.

Authors:  S W Lamberts; M de Quijada; J G Klijn
Journal:  J Endocrinol Invest       Date:  1980 Oct-Dec       Impact factor: 4.256

6.  Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.

Authors:  M Dowsett; A L Harris; I E Smith; S L Jeffcoate
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

7.  Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer.

Authors:  A L Harris; M Dowsett; I E Smith; S Jeffcoate
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

8.  Tamoxifen, aminoglutethimide and danazol: effect of therapy on hormones in post-menopausal patients with breast cancer.

Authors:  R C Coombes; T J Powles; L H Rees; W A Ratcliffe; A G Nash; M Henk; H T Ford; J C Gazet; A M Neville
Journal:  Br J Cancer       Date:  1982-07       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.